Archive

What should courts prioritize in determining antitrust cases: measurable welfare effects, or the protection of competitive rivalry itself? The Consumer Welfare Standard and the Protect Competition Standard offer different answers.

Affordable medicines remain out of reach for millions because pharmaceutical innovation is organized around value extraction, not public health. How do shareholder-driven governance and fragmented global health financing reinforce inequity, and what structural reforms are needed to reverse it?

As the Supreme Court’s unitary executive theory reaches the Federal Reserve, a deeper constitutional question comes into view: who holds the power to make money?

The global medicine-access crisis is not simply a failure to balance innovation and affordability. It reflects a deeper system in which shareholder-driven pharmaceutical governance and fragmented donor structures undermine public health and block the shift toward more equitable value creation.

Less capital, more risk, familiar consequences. The latest move on big-bank rules suggests that too big to fail was never solved, only deferred.

A case for tackling the corporate machinery driving extreme wealth, and the reforms that could truly curb it.

Introduced by the AMA in 2001, Category III CPT codes aimed to streamline financial reporting. Instead they became entangled in a politically driven, zero-sum reimbursement game.

Authors Bill Bergman and Larry Feltes argue that declining public confidence in government and financial institutions is putting the U.S. economy in peril — and a crisis could come faster than you think.

Affordability of electricity and concerns about fossil fuel pollution, water resources, and job loss, have driven a rebellion against data centers that is both grassroots and bipartisan. It’s time for cleaner, faster and cheaper solutions.

Europe’s social media crackdown is less about “speech wars” than a long-overdue attempt to price the public damage created by large platforms.

Health researcher Steven H. Woolf tells INET’s Lynn Parramore why making Americans healthy again means economic policies that help working- and middle-class families. Raw raw milk won’t cut it, and even being rich won’t save you. *This is Part 2 of the interview; Part 1 is here.

In a discussion with INET’s Lynn Parramore, researcher Steven H. Woolf explains how the peculiar features of life, policy, and economics in America are killing us sooner, and what we can do to change it. *This is Part 1 of a two-part interview; Part 2 is here.

Kenneth Rogoff, Our Dollar, Your Problem: An Insider’s View of Seven Turbulent Decades of Global Finance, and the Road Ahead. Yale 2025.

After FTX’s collapse, crypto looked finished. Yet Washington revived it, culminating in Trump’s GENIUS Act and a surprising Democratic shift. How did money and affluence predict pro-crypto votes, amid widening deregulation and cyber risk?

After FTX’s collapse, crypto looked finished. Yet Washington revived it, culminating in Trump’s GENIUS Act and a surprising Democratic shift. How much did money and affluence predict pro-crypto votes, amid widening deregulation and cyber risk?